Reckitt, the maker of Mucinex, is investing an additional $400 million to expand its North Carolina manufacturing plant and New Jersey campus. The move comes as the company responds to shifts in consumer demand for its health and wellness products. The expanded facilities will help strengthen the company's U.S. supply chain capabilities and increase production capacity for key medications and consumer goods.

This latest investment builds on Reckitt's ongoing commitment to domestic manufacturing in North America, ensuring better availability of products like Mucinex and other health-focused brands across the region. The North Carolina and New Jersey locations were chosen for their strategic access to major distribution networks and skilled workforce.